| Glutamatergic Modulation of Motivation Enhancement: A Pilot Feasibility Trial (NCT02373124) | New York State Psychiatric Institute | 2014-12-01 |
| Congenital Muscular Dystrophy Ascending Multiple Dose Cohort Study Analyzing Pharmacokinetics at Three Dose Levels In Children and Adolescents With Assessment of Safety and Tolerability of Omigapil (CALLISTO) (NCT01805024) | Santhera Pharmaceuticals | 2014-12-01 |
| A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy (NCT02251600) | PTC Therapeutics | 2014-12-01 |
| Pharmacokinetic and Safety Study of Cenicriviroc and Pioglitazone, When Dosed Alone or in Combination (NCT02342067) | Tobira Therapeutics, Inc. | 2014-12-01 |
| Effect of SVF Derived MSC in DCD Renal Transplantation (NCT02492490) | Fuzhou General Hospital | 2014-12-01 |
| An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort (NCT02295748) | PTC Therapeutics | 2014-12-01 |
| A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer (NCT02344095) | Seoul National University Hospital | 2014-12-01 |
| Postcoital Testing Study of the SILCS Diaphragm Used With 3% N-9 Gel, ContraGel, or No Gel (NCT02309554) | CONRAD | 2014-12-01 |
| MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT02049801) | Bruno C. Medeiros | 2014-12-01 |
| Ph 1, Single-Center, Safety, Tolerability & Pharmacokinetic Study of KX2 391 Ointment in Subj. w Actinic Keratosis (NCT02337205) | Athenex, Inc. | 2014-12-01 |
| Rivaroxaban Effects in Subjects Who Have Undergone Gastric Bypass Surgery (NCT02058199) | State University of New York - Upstate Medical University | 2014-12-01 |
| Safety, Tolerability and Immunogenicity Study of 2 Dose Levels of Trimeric Glycoprotein140 (gp140) in Healthy Adult Volunteers (NCT02304185) | Crucell Holland BV | 2014-12-01 |
| "Pi" and Hot Flushes (NCT01315041) | Casa Espirita Terra de Ismael | 2014-12-01 |
| Evaluation of the Safety and Efficacy of a Single Dose of a Dengue Vaccine (TV005) in Healthy Adults (NCT02317900) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-12-01 |
| A Safety Study of SGN-CD33A in Combination With Standard-of-care in Patients With AML (NCT02326584) | Seagen Inc. | 2014-12-01 |
| Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid (NCT02274623) | OPKO Health, Inc. | 2014-12-01 |
| Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast Cancer (NCT02129556) | ETOP IBCSG Partners Foundation | 2014-12-01 |
| Safety and Tolerability of Quetiapine in Multiple Sclerosis (NCT02087631) | University of Calgary | 2014-12-01 |
| B-Cell Targeted Carfilzomib Desensitization (NCT02442648) | E. Steve Woodle | 2014-12-01 |
| Feasibility Study of Adjuvant Treatment With S-1 and Oxaliplatin in Patients With Resectable Esophageal Cancer (NCT02347904) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2014-12-01 |
| An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia (NCT02320032) | Alkermes, Inc. | 2014-12-01 |
| Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer (NCT02333188) | University of Chicago | 2014-12-01 |
| A Study of Duvelisib in Combination With Rituximab or Obinutuzumab in Subjects With Previously Untreated CD20+ Follicular Lymphoma (CONTEMPO) (NCT02391545) | SecuraBio | 2014-12-01 |
| A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults. (NCT02326194) | Jiangsu Province Centers for Disease Control and Prevention | 2014-12-01 |
| A Phase 1 Study of an Investigational Drug, ALN-PCSSC, in Subjects With Elevated Low Density Lipoprotein Cholesterol (LDL-C) (NCT02314442) | Alnylam Pharmaceuticals | 2014-12-01 |
| Safety and Efficacity of NFL101 as Tobacco Therapy (NCT02521701) | Institut du Cancer de Montpellier - Val d'Aurelle | 2014-12-01 |
| Combining Intraoperative Radiotherapy With Kyphoplasty for Treatment of Spinal Metastases (NCT02480036) | Loyola University | 2014-12-01 |
| Efficacy Study of Pre-operative IPH2201 in Patients With Squamous Cell Carcinoma of the Oral Cavity (NCT02331875) | Innate Pharma | 2014-12-01 |
| Long Term Safety Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study (NCT02000154) | SymBio Pharmaceuticals | 2014-12-01 |
| Aberrations in Carnitine Homeostasis in Congenital Heart Disease With Increased Pulmonary Blood Flow (NCT01825369) | University of California, San Francisco | 2014-12-01 |
| Gastric Acid Rebound Secretion Measured by Alkaline Tide (NCT01315444) | Rabin Medical Center | 2014-12-01 |
| First-in-Human Single and Multiple Dose of GLPG1837 (NCT02325037) | Lakefront Biotherapeutics NV | 2014-12-01 |
| Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas (NCT02271945) | MedImmune LLC | 2014-12-01 |
| HER2-Peptide Vaccination of Patients With Solid Tumors (NCT02276300) | Technical University of Munich | 2014-12-01 |
| Estradiol-Receptor Blockade in Older Men and Women (NCT02271282) | Mayo Clinic | 2014-12-01 |
| Phase I-B Study to Evaluate the Safety, Tolerability and Efficacy of IZN-6NVS for the Treatment of AV and DIV (NCT02313545) | Izun Pharma Ltd | 2014-12-01 |
| Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women (NCT02272647) | Mayo Clinic | 2014-12-01 |
| Phase 1b/2 Study of Oprozomib in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (NCT02227914) | Amgen | 2014-12-01 |
| Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults (NCT02228772) | Massachusetts General Hospital | 2014-12-01 |
| Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus (NCT02283359) | H. Lee Moffitt Cancer Center and Research Institute | 2014-12-01 |
| Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Study Of PF-04447943, Co-Administered With And Without Hydroxyurea, In Subjects With Stable Sickle Cell Disease (NCT02114203) | Pfizer | 2014-12-01 |
| CNS Uptake of Intranasal Glutathione (NCT02324426) | University of Washington | 2014-12-01 |
| Study of MEN1112 Intravenous Infusion in Relapsed or Refractory Acute Myeloid Leukemia (NCT02353143) | Menarini Group | 2014-12-01 |
| A Phase 1 Study of ProMetic Plasminogen (Human) Intravenous in Adults and Children With Plasminogen Deficiency (NCT02312180) | Prometic Biotherapeutics, Inc. | 2014-12-01 |
| Study of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway Mutations (NCT02278133) | Array BioPharma | 2014-12-01 |
| Drug-Drug Interaction Study: ASP2151 and Montelukast (NCT02321748) | Maruho Europe Limited | 2014-12-01 |
| Furosemide Pharmacodynamics and Pharmacokinetics After Subcutaneous or Oral Administration (NCT02350725) | scPharmaceuticals, Inc. | 2014-12-01 |
| Safety and Pharmacokinetic Study of PF-06651600 in Healthy Volunteers (NCT02309827) | Pfizer | 2014-12-01 |
| A Study of Lispro Formulations in Healthy Participants (NCT02293551) | Eli Lilly and Company | 2014-12-01 |
| Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer (NCT02470468) | SOTIO a.s. | 2014-12-01 |
| Bioequivalence Study of Guaifenesin and Pseudoephedrine Hydrochloride Extended Release Tablets 1200/120 mg Under Fasting Conditions (NCT03706300) | Dr. Reddy's Laboratories Limited | 2014-12-01 |
| Investigation on Safety, Tolerability and Pharmacokinetics of Single Doses of NNC0174-0833 in Normal Weight, Overweight to Obese But Otherwise Healthy Male Subjects (NCT02300844) | Novo Nordisk A/S | 2014-12-01 |
| The Effectiveness of Eldecalcitol in the Bisphosphonate Non-respondered-patients With Osteoporosis (NCT02306187) | Shinshu University | 2014-12-01 |
| Pretreatments of the Skin Prior to PDT (NCT02372370) | Bispebjerg Hospital | 2014-12-01 |
| Induction With SVF Derived MSC in Living-related Kidney Transplantation (NCT02492308) | Fuzhou General Hospital | 2014-12-01 |
| Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans (NCT03020771) | The Scientific and Technological Research Council of Turkey | 2014-12-01 |
| 68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs) (NCT02359500) | Lale Kostakoglu | 2014-12-01 |
| Bioequivalence Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult Volunteers (NCT02300688) | IlDong Pharmaceutical Co Ltd | 2014-12-01 |
| CSCC_ASC Therapy in Patients With Severe Heart Failure (NCT02387723) | JKastrup | 2014-12-01 |
| Phase 1 Study to Explore the Safety and Pharmacokinetics of DAPAglifozin in Adolescents and Adults With Type 1 Diabetes (NCT02325206) | Kinderkrankenhaus auf der Bult | 2014-12-01 |
| CAR T Cells in Treating Patients With Malignant Gliomas Overexpressing EGFR (NCT02331693) | RenJi Hospital | 2014-12-01 |
| TDENV PIV and LAV Dengue Prime-boost Strategy (NCT02239614) | U.S. Army Medical Research and Development Command | 2014-12-01 |
| Stem Cell Gene Therapy for Sickle Cell Disease (NCT02247843) | Donald B. Kohn, M.D. | 2014-12-01 |
| A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430 (NCT02319772) | BioCryst Pharmaceuticals | 2014-12-01 |
| Non-oxidative Metabolite Profiles After Increasing Doses of Ethanol (NCT02311686) | Parc de Salut Mar | 2014-12-01 |
| A Clinical Research of CAR T Cells Targeting CEA Positive Cancer (NCT02349724) | Southwest Hospital, China | 2014-12-01 |
| Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) (NCT02331251) | Western Regional Medical Center | 2014-12-01 |
| The Effect of Multiple Doses of BI 187004 on the Single-dose Pharmacokinetics of Repaglinide and Bupropion in Healthy Male Volunteers (NCT02305901) | Boehringer Ingelheim | 2014-12-01 |
| A Clinical Research of CAR T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma (NCT02349698) | Southwest Hospital, China | 2014-12-01 |
| A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma (NCT02279719) | Sumitomo Pharma America, Inc. | 2014-12-01 |
| A Bioequivalence Study of Daclatasvir Tablets and Bioavailability Studies of Daclatasvir and Asunaprevir (NCT02323594) | Bristol-Myers Squibb | 2014-12-01 |
| A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Disease (NCT02295501) | Cerus Corporation | 2014-12-01 |
| A Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171 (NCT02309320) | Ablynx, a Sanofi company | 2014-12-01 |
| Evaluation and Validation of Endogenous Markers for the Assessment of CYP3A Activity in Korean Healthy Subjects Using Metabolomics (NCT02579434) | Seoul National University Hospital | 2014-12-01 |
| A Study to Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya. (NCT02296983) | University of Oxford | 2014-12-01 |
| A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell Disease (NCT02285088) | Global Blood Therapeutics | 2014-12-01 |
| KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer (NCT02205463) | NYU Langone Health | 2014-12-01 |
| NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors (NCT02300467) | National OncoVenture | 2014-12-01 |
| Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer (NCT01799161) | Eckhard Podack | 2014-12-01 |
| Telavancin Pediatric PK Study (Ages >12 Months to 17 Years) (NCT02013141) | Cumberland Pharmaceuticals | 2014-12-01 |
| to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male Volunteers (NCT02289430) | NVP Healthcare | 2014-12-01 |
| Safety, Tolerability & PK of KX2-361 in Subjects w Adv. Malignancies Refractory to Conventional Therapies (NCT02326441) | Athenex, Inc. | 2014-12-01 |
| A Study of RG7625 in Healthy Volunteers (NCT02295332) | Hoffmann-La Roche | 2014-12-01 |
| A Single Dose Evaluation of the Effects of Moderate Hepatic Impairment on Deflazacort Pharmacokinetics (NCT02286609) | PTC Therapeutics | 2014-12-01 |
| Periodontal Regeneration of Chronic Periodontal Disease Patients Receiving Stem Cells Injection Therapy (NCT02523651) | Songlin Wang | 2014-12-01 |
| Comparison of Laboratory Changes, Food Intake and Metabolic Profile in Patients With Obesity and Type2 Diabetes Mellitus: Before, During and After Taking AphoelineBrake (NCT02791867) | Dasman Diabetes Institute | 2014-12-01 |
| Effects of Probiotics on Oral Health (NCT02444182) | Kuwait University | 2014-12-01 |
| Study of the Effects of TRV130, at Therapeutic and Supra Therapeutic Doses, on QTc Intervals (NCT02344303) | Trevena Inc. | 2014-12-01 |
| Effect of Intranasal Insulin on LH Concentrations in Man (NCT02154477) | Texas Tech University Health Sciences Center | 2014-12-01 |
| Aerosolized Surfactant in Neonatal RDS (NCT02294630) | Sood, Beena G., MD, MS | 2014-12-01 |
| Single-fraction IMRT Versus External Beam Radiotherapy for Patients With Spine Bone Metastases (NCT02358720) | Heidelberg University | 2014-12-01 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of 3 Subcutaneous and 1 Intravenous Dose of E6011 in Subjects With Active Crohn's Disease (NCT02249078) | Eisai Inc. | 2014-12-01 |
| Safety, Attenuation and Immunogenicity of GAP3KO Administered Via A Stephensi Mosquitoes (NCT02313376) | Seattle Children's Hospital | 2014-12-01 |
| Treatment of Fecal Incontinence Using Allogenic-Adipose-derived Mesenchymal Stem Cells: A Prospective, Dose Escalation, Randomized, Placebo-controlled, Parallel-group, Single-blind, Single-center Pilot Study (NCT02384499) | Yonsei University | 2014-12-01 |
| Safety Study of Liver Regeneration Therapy Using Cultured Autologous BMSCs (NCT02327832) | Yamaguchi University Hospital | 2014-12-01 |
| Mephedrone and Alcohol Interactions in Humans (NCT02294266) | Parc de Salut Mar | 2014-12-01 |
| Safety, Tolerability, and Pharmacokinetics of Single Doses of APN1125 in Healthy Normal Subjects (NCT02331433) | CoMentis | 2014-12-01 |
| A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia Patients (NCT02317861) | AstraZeneca | 2014-12-01 |
| Patritumab With Cetuximab and a Platinum Containing Therapy for Patients With Head and Neck Cancer (NCT02350712) | Daiichi Sankyo | 2014-12-01 |
| TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma (NCT01721941) | Scripps Clinic Cancer Center | 2014-12-01 |